LAVA Therapeutics NV Quarterly Liabilities in USD from Q4 2019 to Q4 2023

Taxonomy & unit: ifrs-full: USD
Summary: LAVA Therapeutics NV quarterly Liabilities history and growth rate from Q4 2019 to Q4 2023.
LAVA Therapeutics NV Liabilities for the quarter ending December 31, 2023 was $50.5M, a 11.9% decline year-over-year.

Liabilities, Quarterly (USD)

Liabilities, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q4 2023	$50.5M	-$6.85M	-11.9%	Dec 31, 2023	20-F	2024-03-20
Q4 2022	$57.4M	+$36.5M	+175%	Dec 31, 2022	20-F	2024-03-20
Q4 2021	$20.9M	+$8.02M	+62.3%	Dec 31, 2021	20-F	2023-04-11
Q4 2020	$12.9M	+$9.91M	+336%	Dec 31, 2020	20-F/A	2022-12-23
Q4 2019	$2.95M			Jan 1, 2020	20-F/A	2022-12-23

* An asterisk sign (*) next to the value indicates that the value is likely invalid.